HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
20.55
-0.80 (-3.75%)
Oct 24, 2024, 4:00 PM EDT - Market closed
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for HUTCHMED (China) stock have an average target of 20.55, with a low estimate of 19 and a high estimate of 22.1. The average target predicts no change from the current stock price of 20.55.
Analyst Consensus: Buy
* Price targets were last updated on Aug 1, 2024.
Analyst Ratings
The average analyst rating for HCM stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | -7.54% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +7.54% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -17.27% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +143.31% | Sep 5, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +143.31% | Jul 24, 2023 |
Financial Forecast
Revenue This Year
693.49M
from 838.00M
Decreased by -17.24%
Revenue Next Year
843.15M
from 693.49M
Increased by 21.58%
EPS This Year
-0.11
from 0.12
EPS Next Year
0.04
from -0.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 769.7M | 1.1B | 1.4B | ||
| Avg | 693.5M | 843.2M | 1,000.0M | ||
| Low | 613.6M | 702.7M | 777.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.2% | 52.9% | 62.2% | ||
| Avg | -17.2% | 21.6% | 18.6% | ||
| Low | -26.8% | 1.3% | -7.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.04 | 0.11 | 0.27 | |
| Avg | -0.11 | 0.04 | 0.14 | |
| Low | -0.72 | -0.06 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -64.6% | - | 542.2% | |
| Avg | - | - | 229.7% | |
| Low | - | - | 15.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.